GlassScriptPhysician profile
Seema Rao
NPI 1508807827
$6,707.95
in general payments reported to CMS, 2019-2025
35 companies · $1,527 in 2025
The $1,527 reported for 2025 was more than what 90% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,522 · 2020: $823 · 2021: $377 · 2022: $612 · 2023: $1,092 · 2024: $755 · 2025: $1,527.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,356 · Education: $18.85.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,355.84 |
| Education | $18.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,264.25 | 2019-2025 | Breztri, Farxiga, Airsupra |
| Lilly USA, LLC | $1,050.71 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Novo Nordisk INC | $798.10 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Pfizer INC. | $610.98 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $437.20 | 2019-2025 | Gardasil 9, Capvaxive, Gardasil |
| Sanofi-Aventis U.S. LLC | $352.86 | 2019-2023 | |
| Glaxosmithkline, LLC. | $309.50 | 2019-2024 | Arexvy, Trelegy Ellipta, Shingrix |
| Boehringer Ingelheim Pharmaceuticals, INC. | $279.08 | 2019-2025 | Jardiance |
| Exact Sciences Corporation | $214.00 | 2023-2025 | Cologuard Collection Kit |
| Dexcom, INC. | $167.44 | 2025 | Dexcom G7 Gss (161), Dexcom Stelo Glucose Biosensor, Dexcom G6 Transmitter |
| Amgen INC. | $152.31 | 2019-2025 | Repatha, Otezla, Otezla |
| Abbvie INC. | $122.67 | 2019-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $113.17 | 2021-2025 | |
| Gilead Sciences, INC. | $98.25 | 2024-2025 | |
| Hikma Pharmaceuticals USA | $78.00 | 2019-2020 |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $68.15 | 2019-2024 | |
| Corcept Therapeutics | $57.68 | 2025 | Korlym |
| Regeneron Healthcare Solutions, INC. | $54.15 | 2019-2023 | Evkeeza |
| Janssen Pharmaceuticals, INC | $52.66 | 2019-2023 | Xarelto |
| Astellas Pharma US INC | $48.37 | 2019-2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $39.62 | 2019 | |
| Amarin Pharma, INC. | $35.30 | 2019-2020 | |
| Endo Pharmaceuticals INC. | $33.60 | 2019-2020 | |
| Teva Pharmaceuticals USA, INC. | $33.07 | 2022-2023 | Airduo Digihaler |
| Aimmune Therapeutics, INC. | $32.20 | 2024-2025 | Zenpep |
| Sanofi Pasteur INC. | $29.49 | 2019-2021 | |
| Nestle Healthcare Nutrition INC. | $28.16 | 2022-2023 | |
| Eisai INC. | $24.98 | 2020 | |
| Sumitomo Pharma America, INC. | $22.78 | 2025 | Gemtesa |
| Esperion Therapeutics, INC. | $21.93 | 2025 | Nexletol |
| Viiv Healthcare Company | $20.08 | 2023 | Apretude |
| Kowa Pharmaceuticals America, INC. | $15.81 | 2025 | Zoryve |
| Medtronic, INC. | $14.75 | 2021 | |
| Vistapharm, INC. | $13.62 | 2021 | |
| Horizon Therapeutics Plc | $13.03 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Seema Rao listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.